Multimodal Biomarker Discovery: AI for Early Disease Detection and Patient Stratification

Oct 29, 2026
Discovery Biology

Investigate how AI integrates genomic, proteomic and clinical signals to uncover target-linked biomarkers.

Assess how multimodal analytics are supporting earlier and more precise stratification hypotheses.

Clarify how biomarker-informed validation improves alignment between discovery biology and clinical strategy.

Speakers
Vinayagam Arunachalam
Vinayagam Arunachalam, Senior Director, Head of Computational Biology and Digital | Early Development and Biomarkers, - Takeda
Maen Obeidat
Maen Obeidat, Executive Director-Therapeutic Area Head, Biomarker Development, Translational Medicine - Novartis